Loading...
Symbols:
Loading...
Symbols:
Indevus Pharmaceuticals Inc. (IDEV)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Indevus Pharmaceuticals Inc. (IDEV)
8 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on IDEV
- SA Editor Miriam Metzinger(3)
- Centient Biotech Investor(2)
- Andrew Vaino(1)
- Notable Calls(1)
- Mark Hines(1)
Most popular authors
(tracked in watchlists)
- Andrew Wilkinson(333)
- SA Editor Miriam Metzinger(116)
- Notable Calls(112)
- Andrew Snyder(64)
- Steven Turner (7)
Most commented on authors
- Indevus: Making Big Gains with Approval for Its New Drug
- Indevus Pharmaceuticals: Nebido Has Lost Its Libido
- Wednesday's Options Report: Ikon, IDEV, Verigy, WFC, JNY, PPCO
- Screening for Potential Buyout Targets
- Biotech Day In Review: MedImmune Puts Itself Up For Sale
- Indevus' Sanctura XR Proves Attractive Beside Competitor 'Speed Bumps'
- Biotech Day in Review: Biosite Takes $85 Offer from Beckman Coulter
- Indevus Buyout of Valera to Grow Earnings
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »